Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin.

Authors:
Aimo A; Senni M; Barison A; Panichella G; Passino C and 2 more

Journal:
Heart Fail Rev

Publication Year: 2022

DOI:
10.1007/s10741-022-10228-8

PMCID:
PMC9902425

PMID:
35488030

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Heart Fail Rev

Abbreviation: Heart Fail Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breas…
Gao Y; Wang R; Jiang J and 3 more (2023) - Transparency Score: 3/6
Acute advanced aortic stenosis.
Avvedimento M; Angellotti D; Ilardi F and 11 more (2023) - Transparency Score: 3/6
Advance of echocardiography in cardiac amyloidosis.
Liang S; Liu Z; Li Q and 2 more (2023) - Transparency Score: 2/6
Artificial intelligence models in prediction of response to cardiac resynchronization therapy: a sy…
Nazar W; Szymanowicz S; Nazar K and 4 more (2023) - Transparency Score: 3/6
Effectiveness of mobile telemonitoring applications in heart failure patients: systematic review of…
Rebolledo Del Toro M; Herrera Leaño NM; Barahona-Correa JE and 3 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Funding Open access funding provided by Scuola Superiore Sant'Anna within the CRUI-CARE Agreement."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025